Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure

PHASE2TerminatedINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

June 26, 2018

Primary Completion Date

May 22, 2020

Study Completion Date

May 22, 2020

Conditions
Heart Failure
Interventions
DRUG

Sodium Zirconium Cyclosilicate

Oral use for approximately 3 months

DRUG

Placebo

Oral use for approximately 3 months

Trial Locations (76)

1051

Research Site, Budapest

1096

Research Site, Budapest

1106

Research Site, Budapest

1122

Research Site, Budapest

1202

Research Site, Sofia

1204

Research Site, Budapest

1407

Research Site, Sofia

1527

Research Site, Sofia

3000

Research Site, Hatvan

3529

Research Site, Miskolc

4003

Research Site, Plovdiv

4400

Research Site, Nyíregyháza

6000

Research Site, Kecskemét

6500

Research Site, Baja

6600

Research Site, Szentes

7623

Research Site, Pécs

9700

Research Site, Shumen

11204

Research Site, Brooklyn

19610

Research Site, Wyomissing

32169

Research Site, New Smyrna Beach

33133

Research Site, Miami

33952

Research Site, Port Charlotte

46260

Research Site, Indianapolis

48504

Research Site, Flint

57701

Research Site, Rapid City

71301

Research Site, Alexandria

79935

Research Site, El Paso

91950

Research Site, National City

94305

Research Site, Stanford

97742

Research Site, Brezno

121552

Research Site, Moscow

150062

Research Site, Yaroslavl

170036

Research Site, Tver'

191015

Research Site, Saint Petersburg

200642

Research Site, Craiova

390039

Research Site, Ryazan

400001

Research Site, Cluj-Napoca

500283

Research Site, Brasov

540143

Research Site, Tg Mures

550245

Research Site, Sibiu

614000

Research Site, Perm

620039

Research Site, Yekaterinburg

624002

Research Site, Aramil

630055

Research Site, Novosibirsk

660062

Research Site, Krasnoyarsk

17515000

Research Site, Marília

83430000

Research Site, Campina Grande do Sul

90020090

Research Site, Porto Alegre

06708

Research Site, Waterbury

02115

Research Site, Boston

30140 062

Research Site, Belo Horizonte

30150-240

Research Site, Belo Horizonte

70200-730

Research Site, Brasillia

13060-080

Research Site, Campinas

80010-030

Research Site, Curitiba

20241-180

Research Site, Rio de Janeiro

09090-790

Research Site, Santo André

15090-000

Research Site, São José do Rio Preto

05403-000

Research Site, São Paulo

38411-186

Research Site, Uberlândia

15500-003

Research Site, Votuporanga

V5Z 1M9

Research Site, Vancouver

H1T 1C8

Research Site, Montreal

G1V 4G5

Research Site, Québec

J6E 6J2

Research Site, Saint-Charles-Borromée

G8Z 3R9

Research Site, Trois-Rivières

41-500

Research Site, Chorzów

80-952

Research Site, Gdansk

59-220

Research Site, Legnica

60-848

Research Site, Poznan

35-055

Research Site, Rzeszów

83-110

Research Site, Tczew

042122

Research Site, Bucharest

984 01

Research Site, Lučenec

080 01

Research Site, Prešov

08901

Research Site, Svidník

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY